How can JensonR+ help you?
After the expenditure and effort of product development, it is essential to ensure that you get the best out of your investment.
The field of regulatory affairs encompasses all the work that is necessary to receive and maintain a marketing authorisation or registration for a medicinal product. Dossiers are at the forefront of this process. We can prepare the dossier, publish in the right format and manage the procedure from submission to close-out and our experts can assist you with the preparation of responses to questions raised by the regulatory agency. Once registration is complete, we can support you with ongoing maintenance for the registration dossier. We can also review existing dossiers for gaps and regulatory compliance
Scientific Advice Meetings with regulatory agencies can be very useful. Our team can guide you through the entire process, from making the meeting arrangements and preparing the list of questions with briefing information, through to chairing your meeting and formalising the outcome
Our regulatory specialists can assist with changes in legal status for your prescription medicine portfolio. Our experts will liaise with relevant regulatory authorities, healthcare professional and consumer-patient organisations to determine current opinion and assist in the development of the regulatory affairs strategy. We will also prepare the registration package and manage the regulatory process.
Talk directly to one of our experienced team
Janet Worrell
Head of Regulatory
Ben Smith
Regulatory Affairs Officer

The team at Medilink EM have worked closely with Janet Worrell and the team at Jenson R+. Through her network, Janet has been able to provide our organisation, over a period of more than 6 years, with a wide variety of expert speakers for a series of successful professionally organised events on food supplements. Largely due to Janet’s initiative and hard work, we have formed a unique networking forum for this sector of the life sciences industry within the East Midlands.
Read the latest updates from our Regulatory Affairs Team
Overview of the latest MHRA Post-Transition Guidance
JensonR+ Regulatory Officer, Ben Smith talks through a bitesize overview of the latest MHRA Post-Transition Guidance in this helpful video.
Medicines Management in Sport 03 Nov 2020 11am
Medicines Management in Professional Sport
One aspect of taking the plunge […]
CAP Grandfathering
BREXIT will affect the pharmaceutically industry greatly and with an exit date of 31/12/2020 it is important that you are aware of all the changes that will take place - there are a lot of important dates and pressure points that you need to be aware of.
CBD – the dynamic ingredient. Free to attend Webinar Thursday 29 October
CBD and the latest developments.
Our last Special interest Group (SIG) […]
We would like to talk to you and we will listen.
We aim to understand your objectives, your aspirations and your ultimate goals.